HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Puig/Coty deal

This article was originally published in The Rose Sheet

Executive Summary

Puig Beauty & Fashion Group will expand its presence in the U.S. through a strategic partnership with Coty, firms announce Feb. 24. Effective July 1, Coty Prestige will take over "back office services, logistics, and its strong commercial platform, while Puig will manage the development of its brand portfolio through its own marketing team," companies note. "We have had for some time an ambition to make further inroads into the U.S. market, and this alliance is an important part of realizing that goal," Puig Beauty & Fashion Group CEO Marc Puig says, adding "We are confident the Coty organization is the best possible partner to help us understand the retail landscape and work with us towards the future success for our brands." Barcelona company's fragrance portfolio includes prestige scents under Carolina Herrera, Prada, Nina Ricci, Paco Rabanne and Comme des Garcons...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel